New Type of Liver Cancer Identified: Study

Pediatric liver cancer, a liver cancer that is seen more commonly in adults. Therefore, more accurate diagnoses aids in effective treatment with better outcomes.

Pediatric malignant liver disease, is a rare cancer. Scientists have better defined the disease and have taken a necessary step in achieving an optimum treatment, reveals a new study conducted at Children's Hospital Los Angeles.

The //research into hepatocellular malignant neoplasm-NOS (HEMNOS) is the largest case study of its kind to date. HEMNOS is a recently described entity that has features of the most common pediatric liver cancer hepatoblastoma (HB), and hepatocellular carcinoma (HCC) a liver cancer more commonly seen in adults.

Steroids Ineffective and Possibly Harmful in Pediatric Liver Disease
Treating infants with high doses of steroids fails to improve medical outcomes in the end-stage pediatric liver disease biliary atresia, says a new study.

TOP INSIGHT

Better outcomes in pediatric liver disease patients can be achieved by diagnosing accurately and with more effective treatment.

While HEMNOS typically has been treated much like HCC, the CHLA investigators found that treating HEMNOS like a subtype of hepatoblastoma yielded more positive treatment outcomes in children.

The researchers analyzed 11 patients (ages four to 15) with liver cancer, originally seen from 2000-2016, all of whom received HB-targeted chemotherapy and complete surgical resection.

HEMNOS had been thought to have a very poor prognosis, an impression created by the single previous case series on this topic. However, all of the CHLA patients survived and achieved remission, despite being considered high risk.

Key Cause of Kid�s Severe Liver Disease Meets Its Feasible Treatment Target
Astonishing discovery of a new molecular signature for a caustic and often fatal paediatric liver disease could direct to a novel therapeutic target for the hard-to-treat condition.

"The high survival rate of our patients further supports our argument that HEMNOS is best considered a subtype of hepatoblastoma," said Leo Mascarenhas, MD, MS, deputy director of the Children's Center for Cancer and Blood Diseases and senior author on the study.

"Without such a clear definition of the tumor, patients may be treated inappropriately."

Fresh Lease of Life for Liver Cancer Patients With New Drug Delivery System
A drug delivery system consisting of microscopic cubes may help to deliver an anticancer drug specifically to liver cancer cells.

The investigators performed a series of analyses to better define this unique group of tumors. Their pathology review of pre-chemotherapy specimens showed that six tumors had overlapping tissue features of HB and HCC, four had predominant HB histology, along with focal HCC-like histology and one had HB histology.

"No matter what their original diagnosis, each patient benefited when HEMNOS was treated like hepatoblastoma," said Shengmei Zhou, MD, a pediatric pathologist at CHLA and lead author on the study.

At Least 1 Cup Of Coffee a Day Might Keep Liver Cancer Away
Decaffeinated coffee are associated with reduced risk of liver cancer, including pre-existing liver disease.

Investigators also looked for the expression of the telomerase gene (TERT), a repetitive DNA-protein complex crucial for the survival of cancer cells. They identified TERT expression in nine of the 11 cases.

In their next step, the researchers plan to study the genomic difference of the HEMNOS tumor compared to classic hepatoblastoma and hepatocellular carcinoma to gain new insights into the pathophysiology of this cancer.

Source-Eurekalert